ACA Pharma: [email protected] Azurity Pharmaceuticals: [email protected] ...

Prospective study is designed to evaluate the feasibility and visualization benefits of contrast-enhanced ultra-low-field portable MRI.

Las Vegas, NV / Syndication Cloud / January 23, 2026 / ContrastConnect The American College of Radiology (ACR) and the ...

BERLIN--(BUSINESS WIRE)--Bayer, a global leader in radiology, today announced positive topline results of the pivotal Phase III QUANTI studies evaluating the efficacy and safety of gadoquatrane, an ...

People with a history of allergic-like reactions to iodinated contrast media, which is used in a variety of X-ray-based procedures, such as CT and angiography, are susceptible to similar reactions ...

Despite such guidelines, though, the investigators said there is a lack of evidence-based or widely accepted consensus on ...